Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair, and testicular development.
Seventeen constitutionally short boys were studied throughout puberty. Nine received oxandrolone (0.1 mg/kg/day). Treatment was started before onset of puberty. Eight boys served as control subjects. No significant increase in linear growth or skeletal maturation was observed in the treated group. Likewise the peak height velocity was unchanged. Pubic hair developed similarly in both groups in relation to chronologic and skeletal age. The only significant difference was a diminution in testicular volume index during treatment after bone age of 12 years and until bone age of 14 6/12 years.
D000293:Adolescent; D001827:Body Height; D001846:Bone Development / Q000187:drug effects*; D002648:Child; D004341:Drug Evaluation; D006128:Growth / Q000187:drug effects*; D006130:Growth Disorders / Q000188:drug therapy*; D006197:Hair / Q000254:growth & development; D006801:Humans; D008297:Male; D010074:Oxandrolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011627:Puberty / Q000187:drug effects*; D013737:Testis / Q000187:drug effects / Q000254:growth & development*
D010074:Oxandrolone